| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Seres Therapeutics, Inc. (MCRB) have been net sellers, shedding 490 shares worth roughly $2K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 12.5K | $24.5K | - | |
| Other | 8.7K | $17.0K | - | |
| Other | 8.6K | $16.8K | - | |
| Other | 8.1K | $15.9K | - | |
| Other | 8.0K | $15.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Matthew R. Henn69 | See Remarks | Sale+OE10b5-1 | 927 | $0.54 | $501.23 | -1.2% | +43.6% | +113.4% | |
| Nov 18, 2024 | Teresa L. Young72 | See Remarks | Sale+OE10b5-1 | 735 | $0.54 | $397.64 | -0.8% | +43.6% | +113.4% | |
| Nov 18, 2024 | Lisa von Moltke65 | See Remarks | Sale+OE10b5-1 | 977 | $0.54 | $528.26 | -2.9% | +43.6% | +113.4% | |
| Nov 18, 2024 | Thomas DesRosier69 | Chief Legal Officer and EVP | Sale+OE10b5-1 | 878 | $0.54 | $474.73 | -0.6% | +43.6% | +113.4% | |
| Oct 28, 2024 | Teresa L. Young72 | See Remarks | Sale+OE10b5-1 | 2,983 | $0.69 | $2,058.57 | -3.3% | +20.2% | +22.6% | |
| Oct 28, 2024 | Eric D. Shaff69 | CEO and President | Sale+OE10b5-1 | 8,748 | $0.69 | $6,036.99 | -5.0% | +20.2% | +22.6% | |
| Oct 28, 2024 | Matthew R. Henn69 | See Remarks | Sale+OE10b5-1 | 3,984 | $0.69 | $2,749.36 | -5.0% | +20.2% | +22.6% | |
| Oct 28, 2024 | Lisa von Moltke65 | See Remarks | Sale+OE10b5-1 | 4,334 | $0.69 | $2,991.33 | -12.5% | +20.2% | +22.6% | |
| Oct 28, 2024 | Thomas DesRosier69 | Chief Legal Officer and EVP | Sale+OE10b5-1 | 4,259 | $0.69 | $2,939.14 | -3.1% | +20.2% | +22.6% | |
| Aug 16, 2024 | Thomas DesRosier69 | Chief Legal Officer and EVP | Sale+OE10b5-1 | 873 | $0.84 | $733.32 | -0.7% | -32.7% | -5.1% |